This announcement is a separate document:
先健科技：獲FDA批准的一項研究者發起的LAmbreTM Plus左心耳封堵器系統的上市前臨床於美國獲得醫保覆蓋
LIFETECH SCI: FDA Approved Investigator-initiated Pre-market Clinical Trial of LAmbreTM Plus LAA Closure System Obtained Medical Insurance Coverage in the US
Sep 5, 2022 08:02
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.